资讯

The Gates Foundation has committed an additional $2.5 billion to invest in women's health through 2030. Learn some of the ...
Dr. Zolelwa Sifumba overcame MDR-TB and now fights to raise awareness, reduce stigma, and strengthen TB prevention. Discover ...
The Bill & Melinda Gates Foundation has committed to spending $8.6 billion in 2024 to help meet mounting needs and fund innovative ways to save and improve lives. Many philanthropists are stepping up, ...
The Goalkeepers Report is published every year and charts the progress toward the Global Goals. This year’s report focuses on youth population growth that will affect future world progress. We usually ...
When a mother dies during childbirth, the future dies with her. The world doesn’t just lose everything she is and will be. We also—all too often—lose her child. The chance of a baby reaching their ...
The world's worst child health crisis is malnutrition. Climate change is making it even harder to solve. To protect the world’s children from hunger’s worst effects, we must invest in global health.
The Future of Progress Halfway into the Sustainable Development Goals era, it’s time to change our approach.
Our goal is to expand access to digital financial services so people in the lowest-income communities around the globe can build security and prosperity for themselves, their families, and their ...
LONDON -- Today, 13 pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organisations announced a new, ...
to develop a COVID-19 vaccine that can be produced in large amounts at low cost to meet the pandemic-response needs of low- and middle-income countries ...
Our foundation works with partners, grantees, and governments in 144 countries on urgent issues in global health and development. Our program leaders and other experts can offer perspective and ...
This global crisis requires a shared global response: Collaboration is paramount to overcoming unprecedented challenges and ending the acute phase of COVID-19.